<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Impairment of small intestinal absorption has been described in patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and in animal models of experimental <z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The pathophysiology of this dysfunction has not been elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to investigate the effect of chemical <z:hpo ids='HP_0002583'>colitis</z:hpo> on jejunal fluid absorption and determine the role of the enteric <z:mp ids='MP_0008912'>nervous</z:mp> system and some putative <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>In a rat model of iodoacetamide-induced <z:hpo ids='HP_0002583'>colitis</z:hpo>, jejunal net fluid absorption was evaluated by the in vivo single-pass perfusion technique </plain></SENT>
<SENT sid="4" pm="."><plain>The effects of 1) <z:chebi fb="2" ids="9506">tetrodotoxin</z:chebi> (<z:chebi fb="0" ids="9506">TTX</z:chebi>), 2) benzylalkonium <z:chebi fb="76" ids="17996">chloride</z:chebi> (BAC), 3) <z:chebi fb="8" ids="3374">capsaicin</z:chebi>, 4) vasoactive intestinal <z:chebi fb="1" ids="15841">polypeptide</z:chebi> (VIP) antagonism, 5) nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) synthase (NOS) inhibition, and 6) 5-hydroxytryptamine type 3 and 4 (<z:chebi fb="0" ids="28790">5-HT</z:chebi>(3) and <z:chebi fb="0" ids="28790">5-HT</z:chebi>(4)) receptor antagonism on the changes in fluid movement were investigated </plain></SENT>
<SENT sid="5" pm="."><plain>A significant decrease in jejunal net fluid absorption was found 2 and 4 days after <z:hpo ids='HP_0002583'>colitis</z:hpo> induction: 26 (SD 14) and 28 (SD 19) microl x min(-1) x g dry intestinal wt(-1), respectively [P &lt; 0.0002 compared with sham rats at 61 (SD 6.5) microl x min(-1) x g dry intestinal wt(-1)] </plain></SENT>
<SENT sid="6" pm="."><plain>No histological changes were evident in jejunal sections </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="9506">TTX</z:chebi> and BAC reversed this decrease in fluid absorption: 54 (SD 13) and 44 (SD 14) microl x min(-1) x g dry intestinal wt(-1) (P = 0.0005 and P = 0.019, respectively, compared with <z:hpo ids='HP_0002583'>colitis</z:hpo>) </plain></SENT>
<SENT sid="8" pm="."><plain>Ablation of <z:chebi fb="8" ids="3374">capsaicin</z:chebi>-sensitive primary afferent fibers had a partial effect: 45 (SD 5) microl x min(-1) x g dry intestinal wt(-1) (P = 0.001 and P = 0.003 compared with <z:hpo ids='HP_0002583'>colitis</z:hpo> and sham, respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>Constitutive and neuronal NOS inhibition and VIP antagonism returned jejunal net fluid absorption to <z:mpath ids='MPATH_458'>normal</z:mpath> values: 66 (SD 19), 61 (SD 5), and 56 (SD 14) microl x min(-1) x g dry intestinal wt(-1), respectively </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="28790">5-HT</z:chebi>(3) and <z:chebi fb="0" ids="28790">5-HT</z:chebi>(4) receptor antagonism had no effect </plain></SENT>
<SENT sid="11" pm="."><plain>Chemical <z:hpo ids='HP_0002583'>colitis</z:hpo> is associated with a significant decrease in jejunal net fluid absorption </plain></SENT>
<SENT sid="12" pm="."><plain>This decrease is neurally mediated and involves VIP- and NO-related mechanisms </plain></SENT>
</text></document>